Co-Targeting HMGB1 and EGF signaling for the treatment of NF2 and associated hearing loss

syn52676851

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.48105/CTF.CTF-2023-01-009.pc.gr.172011
studyName: Co-Targeting HMGB1 and EGF signaling for the treatment of NF2 and associated hearing loss
dataStatus: Under Embargo
initiative: Young Investigator Award
studyLeads: Zhenzhen Yin
studyStatus: Withdrawn
diseaseFocus: Neurofibromatosis type 2
institutions: Massachusetts General Hospital
fundingAgency: CTF
relatedStudies: true
studyFileviewId: syn52676861
syn52676852
syn53183758
syn52676853
syn52676861
syn52676854

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Co-Targeting HMGB1 and EGF signaling for the treatment of NF2 and associated hearing loss

syn52676851

Drop files to upload

Co-Targeting HMGB1 and EGF signaling for the treatment of NF2 and associated hearing loss page is loading…